Sign in

CIK 0001372299

  • Non-accelerated filer
  • Smaller reporting company

Ocugen, Inc.

Sign in to watch
Ticker
OCGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 484-328-4701
Business address
11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
Former names
HISTOGENICS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,088,801
in 2 filings, $1.1M under 10b5-1 plans

Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Musunuri Shankar −$1.1M Chief Executive Officer sold 51% of stake
Date Insider Transaction Shares Price Value Owned after
2026-06-11 Coleman Blaise Director Grant or award · Stock Option (Right to Buy) +170,100 170,100
2025-06-05 Coleman Blaise Director Grant or award · Option (Right to Buy) +151,316 151,316

Page 1 of 1 · 2 trades